RSS

women’s health

Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. Read more

News

Global specialty pharma company, Theramex, and private pharma company, Endoceutics, have entered into a definitive agreement for the exclusive licensing of Intrarosa (Prasterone) in Europe, Australia, Russia and the Ukraine. Read more

News

A new speciality pharmaceutical company dedicated to women and their health has been launched through CVC Fund VI’s acquisition of Teva Pharmaceutical Industries international women’s health assets. Read more

News